Jones Financial Companies
CUE icon

Jones Financial Companies’s Cue Biopharma CUE Stock Holding History

Jones Financial Companies’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$96 Hold
13
– – ﹤0.01% 4641
2025
Q4 		$122 Buy
+13
New +$239 ﹤0.01% 4301

Other funds holding CUE

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
GWMR
GC Wealth Management RIA Cambridge, Massachusetts $1.73B AUM 16.14% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
RSWM
Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
AWM
Angeles Wealth Management Santa Monica, California $2.19B AUM 23.13% 1-Year Est. Return

Jones Financial Companies's CUE Position: Q1 2026 in Review

Jones Financial Companies held its Cue Biopharma (CUE) position steady in Q1 2026 at 13 shares worth $96. The position accounts for ﹤0.01% of the portfolio, ranked #4641.

Jones Financial Companies first reported a position in CUE in Q4 2025 and has held it in 2 quarters since. The position peaked at $122 in Q4 2025. 55 funds tracked by Wall St. Rank hold CUE as of Q1 2026.

  • Jones Financial Companies held 13 shares of Cue Biopharma worth $96 as of Q1 2026.
  • Jones Financial Companies left its Cue Biopharma share count unchanged in Q1 2026.
  • Cue Biopharma made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #4641 holding.
  • Jones Financial Companies first reported a position in Cue Biopharma in Q4 2025 and has held it in 2 quarters since.
  • Jones Financial Companies's Cue Biopharma position peaked at $122 in Q4 2025.
  • 55 funds tracked by Wall St. Rank held Cue Biopharma as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.